SOSV

Ria Health is an online platform that provides telehealth services aimed at helping individuals modify their relationship with alcohol. It offers personalized treatment plans that include medication-assisted options and behavioral therapies, all facilitated by licensed healthcare professionals. The platform emphasizes continuous monitoring to help users track their progress and maintain accountability. Ria Health also features a mobile app that provides access to educational materials, support groups, and communication with care teams. This comprehensive approach is designed to assist users in managing alcohol consumption and fostering healthier habits, ultimately addressing the challenges associated with alcohol use disorder.

Unlocked Labs develops targeted probiotics designed to manage specific health conditions. Their first product focuses on reducing kidney stone risk by digesting a stone-forming compound found in healthy foods like leafy vegetables.

BioLattice is a biotechnology company focused on developing tissue-engineered cornea technology. Their primary goal is to provide a viable alternative to donor tissue for full-thickness corneal transplants. The company's innovative technology offers a corneal prototype with vision-correcting capabilities, aiming to restore sight for patients requiring corneal transplants.

FREZENT is a biotechnology company focused on developing innovative therapeutics for advanced-stage cancer patients. It specializes in creating biological inhibitors that target cancer-specific lipid metabolism, aiming to prevent the reactivation of dormant cancer cells.

ZiO Health is a biotechnology company that develops pocket-sized devices featuring proprietary biosensor technology and machine learning algorithms. These devices enable real-time laboratory testing at the point-of-care, enhancing patient care by combining immediate results with individual patient profiles.

Flashaid offers a tech-enabled platform that connects patients, hospitals, and multiple stakeholders, enabling coordinated care and streamlined interactions across the healthcare ecosystem.

Chronus Health develops a portable diagnostic device for delivering point-of-care lab results in minutes. Its device enables real-time diagnosis at the point-of-care, improving time to care and patient outcomes.

Unlocked Labs develops targeted probiotics designed to manage specific health conditions. Their first product focuses on reducing kidney stone risk by digesting a stone-forming compound found in healthy foods like leafy vegetables.

Founded in 2018, Rizlab Health specializes in developing compact blood diagnostic devices. Their flagship product is CytoTracker, a pocket-sized, wireless analyzer powered by artificial intelligence, designed to deliver rapid and affordable white blood cell count analysis.

FREZENT is a biotechnology company focused on developing innovative therapeutics for advanced-stage cancer patients. It specializes in creating biological inhibitors that target cancer-specific lipid metabolism, aiming to prevent the reactivation of dormant cancer cells.

Care Constitution operates a telehealth platform that facilitates remote medical consultations. It uses AI to analyze sound and images during virtual appointments, generating real-time clinical data and automated assessments for healthcare providers.

Metabolomic Diagnostics Ltd., established in 2011 and based in Little Island, Ireland, is a medical diagnostics company focused on early disease detection. It specializes in developing a mass spectrometry-based diagnostic platform that analyzes multiple biomarkers simultaneously, enabling predictive diagnosis of complex diseases. The company's primary application is a blood test for predicting the risk of pre-eclampsia, a pregnancy complication characterized by high blood pressure and protein in the urine, which can lead to restricted blood supply to the fetus. By identifying diagnostic biomarker panels and translating them into clinical assays, Metabolomic Diagnostics aims to improve pregnancy outcomes through early intervention.

Cybele Microbiome is a biotechnology company focused on enhancing skin health through precision control of the microbiome. The company utilizes a proprietary AI platform that integrates machine learning with advanced biotechnology and unique data sources to identify natural prebiotics. These prebiotics are designed to nourish the microbiome, leading to the development of customized skincare products. By employing genetic sequencing methods and sustainable nutrient sources, Cybele Microbiome aims to strengthen the skin's natural barrier and promote overall health and longevity. The innovative approach combines artificial intelligence with microbiome science to revolutionize skincare, enabling consumers to maintain the integrity of their skin through effective and conscientious skincare solutions.

Abby’s Better produces minimally processed, plant-based nut butter snacks and spreads. Their products are all-natural, gluten-free, peanut-free, vegan-friendly, and paleo-compliant, offering health-conscious consumers convenient, wholesome options.

Free to Feed is a company focused on enhancing breastfeeding experiences by providing solutions for detecting food allergens in breast milk. It offers an innovative over-the-counter allergen test that empowers breastfeeding mothers to identify various food proteins in their milk, which is crucial for those concerned about potential infant food allergies or intolerances. The company’s patented testing kits, combined with a mobile application, allow mothers to document the presence of allergens, the timing of milk expression, and any symptoms their infants may exhibit. This comprehensive data collection aids medical professionals in diagnosing and managing food allergies effectively. With a growing recognition of the importance of early allergen introduction to mitigate future allergies, Free to Feed supports parents in navigating these complexities with tailored counseling and technology, ensuring they can confidently meet their breastfeeding goals while safeguarding their infants' health.

Aima is a Vancouver-based company founded in 2019 that focuses on transforming the management of menstrual pain. The company provides a weekly proactive pain management system designed specifically for menstruators, offering personalized and effective solutions to address period pain. Aima's platform aims to empower users by enabling them to manage their pain with greater freedom and dignity. Through its innovative approach, Aima seeks to improve the overall experience of menstruators by providing accessible and tailored pain relief options.

Flashaid offers a tech-enabled platform that connects patients, hospitals, and multiple stakeholders, enabling coordinated care and streamlined interactions across the healthcare ecosystem.

Ria Health is an online platform that provides telehealth services aimed at helping individuals modify their relationship with alcohol. It offers personalized treatment plans that include medication-assisted options and behavioral therapies, all facilitated by licensed healthcare professionals. The platform emphasizes continuous monitoring to help users track their progress and maintain accountability. Ria Health also features a mobile app that provides access to educational materials, support groups, and communication with care teams. This comprehensive approach is designed to assist users in managing alcohol consumption and fostering healthier habits, ultimately addressing the challenges associated with alcohol use disorder.

Metabolomic Diagnostics Ltd., established in 2011 and based in Little Island, Ireland, is a medical diagnostics company focused on early disease detection. It specializes in developing a mass spectrometry-based diagnostic platform that analyzes multiple biomarkers simultaneously, enabling predictive diagnosis of complex diseases. The company's primary application is a blood test for predicting the risk of pre-eclampsia, a pregnancy complication characterized by high blood pressure and protein in the urine, which can lead to restricted blood supply to the fetus. By identifying diagnostic biomarker panels and translating them into clinical assays, Metabolomic Diagnostics aims to improve pregnancy outcomes through early intervention.

Eachday is a Pittsburgh-based digital health management company focused on providing tools and evidence-based techniques for self-managing ADHD. The company offers an ADHD self-management application designed to assist users in effectively managing their daily lives. By tracking behaviors and interests, such as task completion, cognitive failures, and self-reported symptoms, Eachday creates personalized profiles that help users gain insights into their cognitive patterns. This approach enables individuals to visualize their time and develop structured routines, ultimately aiming to alleviate ADHD symptoms as they arise and lessen the cognitive burden associated with everyday activities.

Eachday is a Pittsburgh-based digital health management company focused on providing tools and evidence-based techniques for self-managing ADHD. The company offers an ADHD self-management application designed to assist users in effectively managing their daily lives. By tracking behaviors and interests, such as task completion, cognitive failures, and self-reported symptoms, Eachday creates personalized profiles that help users gain insights into their cognitive patterns. This approach enables individuals to visualize their time and develop structured routines, ultimately aiming to alleviate ADHD symptoms as they arise and lessen the cognitive burden associated with everyday activities.

PhableCare creates an ecosystem of patients, doctors, hospitals, health devices, insurance, and patient care service providers. In India, 1 in 4 people suffer from chronic ailments. Meanwhile, 80% of patients cannot comply to the treatment plan provided by the doctor leading to even more complications. This poses a huge burden on the healthcare system. Phable solves this by making care autonomous and predictive. Our AI-enabled health assistant significantly improves health outcomes by enabling disease-specific guidance and continuous monitoring.

Free to Feed is a company focused on enhancing breastfeeding experiences by providing solutions for detecting food allergens in breast milk. It offers an innovative over-the-counter allergen test that empowers breastfeeding mothers to identify various food proteins in their milk, which is crucial for those concerned about potential infant food allergies or intolerances. The company’s patented testing kits, combined with a mobile application, allow mothers to document the presence of allergens, the timing of milk expression, and any symptoms their infants may exhibit. This comprehensive data collection aids medical professionals in diagnosing and managing food allergies effectively. With a growing recognition of the importance of early allergen introduction to mitigate future allergies, Free to Feed supports parents in navigating these complexities with tailored counseling and technology, ensuring they can confidently meet their breastfeeding goals while safeguarding their infants' health.

Chronus Health develops a portable diagnostic device for delivering point-of-care lab results in minutes. Its device enables real-time diagnosis at the point-of-care, improving time to care and patient outcomes.

Unlocked Labs develops targeted probiotics designed to manage specific health conditions. Their first product focuses on reducing kidney stone risk by digesting a stone-forming compound found in healthy foods like leafy vegetables.

Founded in 2018, Rizlab Health specializes in developing compact blood diagnostic devices. Their flagship product is CytoTracker, a pocket-sized, wireless analyzer powered by artificial intelligence, designed to deliver rapid and affordable white blood cell count analysis.

Founded in 2018, Rizlab Health specializes in developing compact blood diagnostic devices. Their flagship product is CytoTracker, a pocket-sized, wireless analyzer powered by artificial intelligence, designed to deliver rapid and affordable white blood cell count analysis.

Microgenesis is a biotechnology company focused on fertility and pregnancy health monitoring. It has developed a platform that provides a non-invasive fertility test and personalized nutritional supplementation aimed at restoring women's fertility potential. The company's innovative diagnostic approach detects subclinical inflammation that negatively impacts ovarian function and implantation, specifically targeting women who have experienced challenges, including multiple failed IVF attempts. Operating out of a CLIA lab in Oakland, Microgenesis offers its solutions through OB-GYNs and direct-to-consumer channels. Additionally, the platform addresses imbalances in vaginal and intestinal microbiota linked to infertility and offers dual testing for immunological issues related to the endometrium, equipping patients with effective treatment options for complex reproductive health cases.

The CareVoice Limited is a Shanghai-based company founded in 2013 that specializes in mobile-based, data-driven software solutions aimed at enhancing the healthcare experience in China. The company provides a platform that offers community-sourced ratings and recommendations for healthcare services, including hospitals, doctors, and treatments. Patients can share their experiences through ratings and reviews, fostering a collaborative environment for individuals undergoing similar medical journeys. By digitalizing the healthcare and insurance processes, The CareVoice aims to create a more consumer-centric approach to healthcare, facilitating better decision-making for patients and improving overall patient experiences. The company also has an office in Hong Kong, reflecting its international presence in the health insurtech sector.

Ria Health is an online platform that provides telehealth services aimed at helping individuals modify their relationship with alcohol. It offers personalized treatment plans that include medication-assisted options and behavioral therapies, all facilitated by licensed healthcare professionals. The platform emphasizes continuous monitoring to help users track their progress and maintain accountability. Ria Health also features a mobile app that provides access to educational materials, support groups, and communication with care teams. This comprehensive approach is designed to assist users in managing alcohol consumption and fostering healthier habits, ultimately addressing the challenges associated with alcohol use disorder.

Chronus Health develops a portable diagnostic device for delivering point-of-care lab results in minutes. Its device enables real-time diagnosis at the point-of-care, improving time to care and patient outcomes.

Abby’s Better produces minimally processed, plant-based nut butter snacks and spreads. Their products are all-natural, gluten-free, peanut-free, vegan-friendly, and paleo-compliant, offering health-conscious consumers convenient, wholesome options.

Basin Genomics is combining scientific backgrounds in genomics and oncology with startup expertise to translate genetic discoveries into advances in personalized clinical care as it strives to develop technology that will decrease the rates of cervical cancer globally.

Basin Genomics is combining scientific backgrounds in genomics and oncology with startup expertise to translate genetic discoveries into advances in personalized clinical care as it strives to develop technology that will decrease the rates of cervical cancer globally.

Free to Feed is a company focused on enhancing breastfeeding experiences by providing solutions for detecting food allergens in breast milk. It offers an innovative over-the-counter allergen test that empowers breastfeeding mothers to identify various food proteins in their milk, which is crucial for those concerned about potential infant food allergies or intolerances. The company’s patented testing kits, combined with a mobile application, allow mothers to document the presence of allergens, the timing of milk expression, and any symptoms their infants may exhibit. This comprehensive data collection aids medical professionals in diagnosing and managing food allergies effectively. With a growing recognition of the importance of early allergen introduction to mitigate future allergies, Free to Feed supports parents in navigating these complexities with tailored counseling and technology, ensuring they can confidently meet their breastfeeding goals while safeguarding their infants' health.

PhableCare creates an ecosystem of patients, doctors, hospitals, health devices, insurance, and patient care service providers. In India, 1 in 4 people suffer from chronic ailments. Meanwhile, 80% of patients cannot comply to the treatment plan provided by the doctor leading to even more complications. This poses a huge burden on the healthcare system. Phable solves this by making care autonomous and predictive. Our AI-enabled health assistant significantly improves health outcomes by enabling disease-specific guidance and continuous monitoring.

Microgenesis is a biotechnology company focused on fertility and pregnancy health monitoring. It has developed a platform that provides a non-invasive fertility test and personalized nutritional supplementation aimed at restoring women's fertility potential. The company's innovative diagnostic approach detects subclinical inflammation that negatively impacts ovarian function and implantation, specifically targeting women who have experienced challenges, including multiple failed IVF attempts. Operating out of a CLIA lab in Oakland, Microgenesis offers its solutions through OB-GYNs and direct-to-consumer channels. Additionally, the platform addresses imbalances in vaginal and intestinal microbiota linked to infertility and offers dual testing for immunological issues related to the endometrium, equipping patients with effective treatment options for complex reproductive health cases.

EMBER Medical is a telehealth company based in San Francisco, California, founded in 2018. It develops a mobile application that connects individuals experiencing medical emergencies with nearby healthcare professionals, including physicians, nurses, and emergency medical technicians, within a five-minute radius. The application features in-app audio and video capabilities, allowing users to communicate directly with medical staff for immediate assistance. EMBER Medical aims to enhance the accessibility of healthcare, particularly in underserved areas, by providing a platform that enables patients to receive timely and personalized care without the need for in-person visits. The company's technology also offers healthcare providers various tools to manage virtual consultations effectively.

Transforming the performance of protein powders through our patent-pending Ingredient Optimization process to increase sustainability and improve health outcomes.

Microgenesis is a biotechnology company focused on fertility and pregnancy health monitoring. It has developed a platform that provides a non-invasive fertility test and personalized nutritional supplementation aimed at restoring women's fertility potential. The company's innovative diagnostic approach detects subclinical inflammation that negatively impacts ovarian function and implantation, specifically targeting women who have experienced challenges, including multiple failed IVF attempts. Operating out of a CLIA lab in Oakland, Microgenesis offers its solutions through OB-GYNs and direct-to-consumer channels. Additionally, the platform addresses imbalances in vaginal and intestinal microbiota linked to infertility and offers dual testing for immunological issues related to the endometrium, equipping patients with effective treatment options for complex reproductive health cases.

Hisens is a company that specializes in developing innovative solutions for monitoring erectile dysfunction through an "underwearable" sensor. The firm creates wearable sensors and a mobile application that collect physiological data in real-time while users sleep. This technology allows for professional data analysis and diagnosis, facilitating personalized treatment plans. Users can track their own health data, monitor treatment progress, assess the effectiveness of various treatment options, and communicate directly with healthcare professionals. By providing these tools, Hisens aims to enhance patient engagement and improve outcomes in the management of erectile dysfunction.

Cybele Microbiome is a biotechnology company focused on enhancing skin health through precision control of the microbiome. The company utilizes a proprietary AI platform that integrates machine learning with advanced biotechnology and unique data sources to identify natural prebiotics. These prebiotics are designed to nourish the microbiome, leading to the development of customized skincare products. By employing genetic sequencing methods and sustainable nutrient sources, Cybele Microbiome aims to strengthen the skin's natural barrier and promote overall health and longevity. The innovative approach combines artificial intelligence with microbiome science to revolutionize skincare, enabling consumers to maintain the integrity of their skin through effective and conscientious skincare solutions.

Cybele Microbiome is a biotechnology company focused on enhancing skin health through precision control of the microbiome. The company utilizes a proprietary AI platform that integrates machine learning with advanced biotechnology and unique data sources to identify natural prebiotics. These prebiotics are designed to nourish the microbiome, leading to the development of customized skincare products. By employing genetic sequencing methods and sustainable nutrient sources, Cybele Microbiome aims to strengthen the skin's natural barrier and promote overall health and longevity. The innovative approach combines artificial intelligence with microbiome science to revolutionize skincare, enabling consumers to maintain the integrity of their skin through effective and conscientious skincare solutions.

Metabolomic Diagnostics Ltd., established in 2011 and based in Little Island, Ireland, is a medical diagnostics company focused on early disease detection. It specializes in developing a mass spectrometry-based diagnostic platform that analyzes multiple biomarkers simultaneously, enabling predictive diagnosis of complex diseases. The company's primary application is a blood test for predicting the risk of pre-eclampsia, a pregnancy complication characterized by high blood pressure and protein in the urine, which can lead to restricted blood supply to the fetus. By identifying diagnostic biomarker panels and translating them into clinical assays, Metabolomic Diagnostics aims to improve pregnancy outcomes through early intervention.

Ivy Natal is a biotechnology company focused on addressing infertility through innovative reproductive solutions. The company has developed a skin biopsy technology that enables the creation of human egg cells from skin samples. This process activates the existing DNA within skin cells to transform them into healthy egg cells, offering a novel alternative to traditional in vitro methods for producing eggs and sperm. By circumventing the challenges associated with conventional reproductive techniques, Ivy Natal aims to provide couples, including those in same-sex relationships, with the opportunity to have genetically related children.

Chronus Health develops a portable diagnostic device for delivering point-of-care lab results in minutes. Its device enables real-time diagnosis at the point-of-care, improving time to care and patient outcomes.

Seein Health is a company focused on developing products that support pregnancy and fertility. Its product range includes thermometers, menstrual test strips, and advanced physiological parameter monitoring equipment. These offerings are designed to ensure the health and safety of pregnant individuals, facilitating a proactive approach to fertility and pregnancy management. In addition to its core product line, Seein Health also provides innovative medical and hardware services, as well as overseas options for test-tube baby frozen eggs, further enhancing its commitment to reproductive health.

The CareVoice Limited is a Shanghai-based company founded in 2013 that specializes in mobile-based, data-driven software solutions aimed at enhancing the healthcare experience in China. The company provides a platform that offers community-sourced ratings and recommendations for healthcare services, including hospitals, doctors, and treatments. Patients can share their experiences through ratings and reviews, fostering a collaborative environment for individuals undergoing similar medical journeys. By digitalizing the healthcare and insurance processes, The CareVoice aims to create a more consumer-centric approach to healthcare, facilitating better decision-making for patients and improving overall patient experiences. The company also has an office in Hong Kong, reflecting its international presence in the health insurtech sector.

Rize Health operates a virtual marketplace and patient management platform for clinical trials, connecting patients with suitable studies and enabling digital participation. The platform supports onboarding, scheduling, and remote data capture to streamline enrollment and reduce dropout rates for researchers, while improving trial efficiency. Headquartered in London, Ontario, the company focuses on patient engagement through a patient-centric interface that matches individuals to appropriate trials.

PhableCare creates an ecosystem of patients, doctors, hospitals, health devices, insurance, and patient care service providers. In India, 1 in 4 people suffer from chronic ailments. Meanwhile, 80% of patients cannot comply to the treatment plan provided by the doctor leading to even more complications. This poses a huge burden on the healthcare system. Phable solves this by making care autonomous and predictive. Our AI-enabled health assistant significantly improves health outcomes by enabling disease-specific guidance and continuous monitoring.

ZiO Health is a biotechnology company that develops pocket-sized devices featuring proprietary biosensor technology and machine learning algorithms. These devices enable real-time laboratory testing at the point-of-care, enhancing patient care by combining immediate results with individual patient profiles.

Chronus Health develops a portable diagnostic device for delivering point-of-care lab results in minutes. Its device enables real-time diagnosis at the point-of-care, improving time to care and patient outcomes.

Beeline Therapeutics is an early-stage preclinical cell therapy company focused on developing next-generation immune cell therapies for immune-mediated diseases, where the body's immune cells mistakenly attack healthy tissue. The company specializes in genetically engineering a patient's own immune cells, specifically Regulatory T cells, to secrete therapeutic proteins in vivo and promote tolerance. By enhancing the function of these re-engineered Tregs, Beeline aims to produce optimal quantities of immunomodulatory cytokines, antibodies, and other therapeutic proteins. Additionally, the company is working on improving antigen specificity through targeting receptors, which aids in better localization of these engineered cells within the body, ultimately contributing to the advancement of innovative treatments for immune-mediated human diseases.

Bioptamers develops personalized cancer therapies using synthetic aptamers, which are short nucleic acid molecules that selectively bind to cancer cells. This enables targeted delivery of chemotherapy, radiation, and immunotherapy agents, aiming to improve clinical outcomes for cancer patients.

Seein Health is a company focused on developing products that support pregnancy and fertility. Its product range includes thermometers, menstrual test strips, and advanced physiological parameter monitoring equipment. These offerings are designed to ensure the health and safety of pregnant individuals, facilitating a proactive approach to fertility and pregnancy management. In addition to its core product line, Seein Health also provides innovative medical and hardware services, as well as overseas options for test-tube baby frozen eggs, further enhancing its commitment to reproductive health.

11 Biomics LLC, headquartered in Albuquerque, New Mexico, is a biotechnology company specializing in the development of biological therapeutics for the cannabis industry. The company focuses on providing treatments and protection against fungal and bacterial diseases affecting both cannabis and hemp plants. 11 Biomics operates at various scales to address these issues, aiming to support the health and productivity of cannabis crops.

Achiko AG is a technology-driven company based in Zürich, Switzerland, with additional offices in Jakarta and Singapore. Established in 2018, it focuses on developing innovative diagnostic solutions and mobile health applications. Its flagship product is a rapid, affordable, and accurate Covid-19 test, which is accompanied by a user-friendly app that serves as a digital health passport. The company's biotechnology division, AptameX, specializes in creating aptamer-based diagnostics, while its digital health technology division, Teman Sehat, enhances the user experience through companion health apps. Achiko's products are designed to be cost-effective and can be rapidly synthesized, positioning the company to address a wide array of disease diagnostics and therapeutic indications in the evolving healthcare landscape.

Seein Health is a company focused on developing products that support pregnancy and fertility. Its product range includes thermometers, menstrual test strips, and advanced physiological parameter monitoring equipment. These offerings are designed to ensure the health and safety of pregnant individuals, facilitating a proactive approach to fertility and pregnancy management. In addition to its core product line, Seein Health also provides innovative medical and hardware services, as well as overseas options for test-tube baby frozen eggs, further enhancing its commitment to reproductive health.

Chronus Health develops a portable diagnostic device for delivering point-of-care lab results in minutes. Its device enables real-time diagnosis at the point-of-care, improving time to care and patient outcomes.

EMBER Medical is a telehealth company based in San Francisco, California, founded in 2018. It develops a mobile application that connects individuals experiencing medical emergencies with nearby healthcare professionals, including physicians, nurses, and emergency medical technicians, within a five-minute radius. The application features in-app audio and video capabilities, allowing users to communicate directly with medical staff for immediate assistance. EMBER Medical aims to enhance the accessibility of healthcare, particularly in underserved areas, by providing a platform that enables patients to receive timely and personalized care without the need for in-person visits. The company's technology also offers healthcare providers various tools to manage virtual consultations effectively.

ZiO Health is a biotechnology company that develops pocket-sized devices featuring proprietary biosensor technology and machine learning algorithms. These devices enable real-time laboratory testing at the point-of-care, enhancing patient care by combining immediate results with individual patient profiles.

Hisens is a company that specializes in developing innovative solutions for monitoring erectile dysfunction through an "underwearable" sensor. The firm creates wearable sensors and a mobile application that collect physiological data in real-time while users sleep. This technology allows for professional data analysis and diagnosis, facilitating personalized treatment plans. Users can track their own health data, monitor treatment progress, assess the effectiveness of various treatment options, and communicate directly with healthcare professionals. By providing these tools, Hisens aims to enhance patient engagement and improve outcomes in the management of erectile dysfunction.

Metabolomic Diagnostics Ltd., established in 2011 and based in Little Island, Ireland, is a medical diagnostics company focused on early disease detection. It specializes in developing a mass spectrometry-based diagnostic platform that analyzes multiple biomarkers simultaneously, enabling predictive diagnosis of complex diseases. The company's primary application is a blood test for predicting the risk of pre-eclampsia, a pregnancy complication characterized by high blood pressure and protein in the urine, which can lead to restricted blood supply to the fetus. By identifying diagnostic biomarker panels and translating them into clinical assays, Metabolomic Diagnostics aims to improve pregnancy outcomes through early intervention.

The CareVoice Limited is a Shanghai-based company founded in 2013 that specializes in mobile-based, data-driven software solutions aimed at enhancing the healthcare experience in China. The company provides a platform that offers community-sourced ratings and recommendations for healthcare services, including hospitals, doctors, and treatments. Patients can share their experiences through ratings and reviews, fostering a collaborative environment for individuals undergoing similar medical journeys. By digitalizing the healthcare and insurance processes, The CareVoice aims to create a more consumer-centric approach to healthcare, facilitating better decision-making for patients and improving overall patient experiences. The company also has an office in Hong Kong, reflecting its international presence in the health insurtech sector.

Daeki has developed the saliva-based diabetes detection test, which provides a simple, quick and non-invasive alternative for patients to detect diabetes or prediabetes conditions at home.

Nivien Therapeutics is a biomedical company focused on developing medicines that enhance chemotherapy and immunotherapy for treatment-resistant cancers. Founded in 2016 and based in Boston, Massachusetts, the company has developed first small-molecule inhibitors targeting the Hippo signaling pathway, a mechanism implicated in cancer resistance. Its program aims to de-risk transfers of technology assets from leading research institutes and to build a platform that advances IO-chemo combination therapies, with an emphasis on expanding options for patients who do not respond to standard treatments.

Abby’s Better produces minimally processed, plant-based nut butter snacks and spreads. Their products are all-natural, gluten-free, peanut-free, vegan-friendly, and paleo-compliant, offering health-conscious consumers convenient, wholesome options.

Proteorex Therapeutics Inc. is a biotechnology company focused on developing innovative therapeutics for diseases with significant unmet medical needs. Founded in 2014 and based in Toronto, Canada, the company specializes in manufacturing small molecule drugs that target challenging diseases. Utilizing a proprietary platform technology, Proteorex integrates novel synthesis design strategies, computational modeling, and patient-derived cell-based screening to identify and develop new lead compounds. This approach enables the company to unlock druggable targets that have previously been considered undruggable, particularly in the field of oncology. Proteorex also maintains an office in San Francisco, further enhancing its capabilities in drug discovery and development.

ZiO Health is a biotechnology company that develops pocket-sized devices featuring proprietary biosensor technology and machine learning algorithms. These devices enable real-time laboratory testing at the point-of-care, enhancing patient care by combining immediate results with individual patient profiles.

Founded in 2017, SwaLife Biotech specializes in discovering and developing medicinal compounds derived from plants. The company focuses on novel anticancer plant alkaloids targeting DNA damage response for both cosmetic and medical applications.

Canuevo Biotech Inc. specializes in the development of cannabinoid (CBD) formulations and innovative drug delivery mechanisms aimed at enhancing the efficacy of these products. Founded in 2017 and headquartered in Fredericton, Canada, the company designs custom vessels for encapsulated CBD, offering a range of products, including skin creams and tablets. Canuevo's formulations target various neurological and movement disorders, such as epilepsy, Parkinson’s disease, and Alzheimer’s, as well as chronic inflammation and childhood disorders. The company also addresses the challenges of standardization and acceptance of cannabis-derived medications within the medical community, focusing on conditions like irritable bowel syndrome and pain regulation. Canuevo Biotech sells its products online, aiming to provide effective solutions for patients in need.

ZiO Health is a biotechnology company that develops pocket-sized devices featuring proprietary biosensor technology and machine learning algorithms. These devices enable real-time laboratory testing at the point-of-care, enhancing patient care by combining immediate results with individual patient profiles.

The CareVoice Limited is a Shanghai-based company founded in 2013 that specializes in mobile-based, data-driven software solutions aimed at enhancing the healthcare experience in China. The company provides a platform that offers community-sourced ratings and recommendations for healthcare services, including hospitals, doctors, and treatments. Patients can share their experiences through ratings and reviews, fostering a collaborative environment for individuals undergoing similar medical journeys. By digitalizing the healthcare and insurance processes, The CareVoice aims to create a more consumer-centric approach to healthcare, facilitating better decision-making for patients and improving overall patient experiences. The company also has an office in Hong Kong, reflecting its international presence in the health insurtech sector.

Hisens is a company that specializes in developing innovative solutions for monitoring erectile dysfunction through an "underwearable" sensor. The firm creates wearable sensors and a mobile application that collect physiological data in real-time while users sleep. This technology allows for professional data analysis and diagnosis, facilitating personalized treatment plans. Users can track their own health data, monitor treatment progress, assess the effectiveness of various treatment options, and communicate directly with healthcare professionals. By providing these tools, Hisens aims to enhance patient engagement and improve outcomes in the management of erectile dysfunction.

Vitali Wear is a Vancouver-based company founded in 2016 that specializes in the development of innovative wellness apparel, specifically a smart bra designed for everyday use. This product incorporates fabric sensors that monitor key indicators such as breathing, posture, and heart rate variability, allowing users to gain insights into their bodily patterns and overall well-being. The data collected is transmitted to a mobile application, which tracks personal goals and progress while also providing access to breathing and meditation exercises. Vitali Wear aims to promote mindfulness and resilience through its technology, encouraging users to foster a deeper connection with themselves and enhance their everyday health.

Vitali Wear is a Vancouver-based company founded in 2016 that specializes in the development of innovative wellness apparel, specifically a smart bra designed for everyday use. This product incorporates fabric sensors that monitor key indicators such as breathing, posture, and heart rate variability, allowing users to gain insights into their bodily patterns and overall well-being. The data collected is transmitted to a mobile application, which tracks personal goals and progress while also providing access to breathing and meditation exercises. Vitali Wear aims to promote mindfulness and resilience through its technology, encouraging users to foster a deeper connection with themselves and enhance their everyday health.

Ria Health is an online platform that provides telehealth services aimed at helping individuals modify their relationship with alcohol. It offers personalized treatment plans that include medication-assisted options and behavioral therapies, all facilitated by licensed healthcare professionals. The platform emphasizes continuous monitoring to help users track their progress and maintain accountability. Ria Health also features a mobile app that provides access to educational materials, support groups, and communication with care teams. This comprehensive approach is designed to assist users in managing alcohol consumption and fostering healthier habits, ultimately addressing the challenges associated with alcohol use disorder.

Hisens is a company that specializes in developing innovative solutions for monitoring erectile dysfunction through an "underwearable" sensor. The firm creates wearable sensors and a mobile application that collect physiological data in real-time while users sleep. This technology allows for professional data analysis and diagnosis, facilitating personalized treatment plans. Users can track their own health data, monitor treatment progress, assess the effectiveness of various treatment options, and communicate directly with healthcare professionals. By providing these tools, Hisens aims to enhance patient engagement and improve outcomes in the management of erectile dysfunction.

Transforming the performance of protein powders through our patent-pending Ingredient Optimization process to increase sustainability and improve health outcomes.

Zeraph is a company focused on enhancing quality of life through the development of connected digital devices for consumers. Its flagship product, Flo, is a contact-free smart thermometer designed for ease of use, particularly for parents tracking their children's body temperature. Flo features a unique object mode that allows users to check the temperature of milk and food, making it versatile for household use. The thermometer connects wirelessly to a free mobile application, enabling users to conveniently monitor their health and maintain accurate temperature records. By prioritizing user-friendly design and connectivity, Zeraph aims to simplify health management for families.

Metabolomic Diagnostics Ltd., established in 2011 and based in Little Island, Ireland, is a medical diagnostics company focused on early disease detection. It specializes in developing a mass spectrometry-based diagnostic platform that analyzes multiple biomarkers simultaneously, enabling predictive diagnosis of complex diseases. The company's primary application is a blood test for predicting the risk of pre-eclampsia, a pregnancy complication characterized by high blood pressure and protein in the urine, which can lead to restricted blood supply to the fetus. By identifying diagnostic biomarker panels and translating them into clinical assays, Metabolomic Diagnostics aims to improve pregnancy outcomes through early intervention.

Cell Reserves is a Canadian biopharmaceutical company specializing in the development of protein and peptide-based therapeutics. It employs molecular shields to enhance the bio-availability and longevity of these therapies, aiming to improve treatment outcomes for autoimmune diseases and excessive inflammation.

Transforming the performance of protein powders through our patent-pending Ingredient Optimization process to increase sustainability and improve health outcomes.

ChugaChaga Inc. is a producer of all-natural teas made from 100% wild-crafted chaga, a medicinal mushroom known for its immune-boosting and antioxidant properties. Founded in 2014 and based in Huguenot, New York, the company offers a range of tea flavors, including original, peach, mint maple, and cherry vanilla. In addition to its tea products, ChugaChaga also sells branded merchandise online. The company is committed to using high-quality ingredients to create health-conscious beverages that cater to evolving dietary needs. Through its offerings, ChugaChaga aims to promote a more natural and nourishing approach to nutrition.

The CareVoice Limited is a Shanghai-based company founded in 2013 that specializes in mobile-based, data-driven software solutions aimed at enhancing the healthcare experience in China. The company provides a platform that offers community-sourced ratings and recommendations for healthcare services, including hospitals, doctors, and treatments. Patients can share their experiences through ratings and reviews, fostering a collaborative environment for individuals undergoing similar medical journeys. By digitalizing the healthcare and insurance processes, The CareVoice aims to create a more consumer-centric approach to healthcare, facilitating better decision-making for patients and improving overall patient experiences. The company also has an office in Hong Kong, reflecting its international presence in the health insurtech sector.

Home to ALL-NATURAL, HEALTH-CONSCIOUS DESSERTS. At Kira's Kiss, they bring you a healthy alternative to sugary and cholesterol-laden foods - but never skimp on SUBLIME GOURMET TASTES. Here at Kira's Kiss, they make fantastic desserts without any preservatives, chemicals or trans-fats. They use only the finest all-natural domestic and imported ingredients. All of their products are MANUFACTURED IN THE USA with the freshest possible ingredients. Their premiere line of health conscious cupcakes are specially formulated no sugar added, lower calorie, low sugar treats. Their proprietary baking techniques and recipes allow us to create lush, voluminous, rich cakes that are filled with a full, creamy symphonic flavor. You will never experience a trace of the flatness, gumminess or chemical aftertaste common with typical "diet" options.

Metabolomic Diagnostics Ltd., established in 2011 and based in Little Island, Ireland, is a medical diagnostics company focused on early disease detection. It specializes in developing a mass spectrometry-based diagnostic platform that analyzes multiple biomarkers simultaneously, enabling predictive diagnosis of complex diseases. The company's primary application is a blood test for predicting the risk of pre-eclampsia, a pregnancy complication characterized by high blood pressure and protein in the urine, which can lead to restricted blood supply to the fetus. By identifying diagnostic biomarker panels and translating them into clinical assays, Metabolomic Diagnostics aims to improve pregnancy outcomes through early intervention.

Metabolomic Diagnostics Ltd., established in 2011 and based in Little Island, Ireland, is a medical diagnostics company focused on early disease detection. It specializes in developing a mass spectrometry-based diagnostic platform that analyzes multiple biomarkers simultaneously, enabling predictive diagnosis of complex diseases. The company's primary application is a blood test for predicting the risk of pre-eclampsia, a pregnancy complication characterized by high blood pressure and protein in the urine, which can lead to restricted blood supply to the fetus. By identifying diagnostic biomarker panels and translating them into clinical assays, Metabolomic Diagnostics aims to improve pregnancy outcomes through early intervention.

Metabolomic Diagnostics Ltd., established in 2011 and based in Little Island, Ireland, is a medical diagnostics company focused on early disease detection. It specializes in developing a mass spectrometry-based diagnostic platform that analyzes multiple biomarkers simultaneously, enabling predictive diagnosis of complex diseases. The company's primary application is a blood test for predicting the risk of pre-eclampsia, a pregnancy complication characterized by high blood pressure and protein in the urine, which can lead to restricted blood supply to the fetus. By identifying diagnostic biomarker panels and translating them into clinical assays, Metabolomic Diagnostics aims to improve pregnancy outcomes through early intervention.

Metabolomic Diagnostics Ltd., established in 2011 and based in Little Island, Ireland, is a medical diagnostics company focused on early disease detection. It specializes in developing a mass spectrometry-based diagnostic platform that analyzes multiple biomarkers simultaneously, enabling predictive diagnosis of complex diseases. The company's primary application is a blood test for predicting the risk of pre-eclampsia, a pregnancy complication characterized by high blood pressure and protein in the urine, which can lead to restricted blood supply to the fetus. By identifying diagnostic biomarker panels and translating them into clinical assays, Metabolomic Diagnostics aims to improve pregnancy outcomes through early intervention.